302.50
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Eli Lilly and Co | LLY | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.0% | 302.50 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 302.50 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 220.20 - 335.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 302.50 | USD |
Period:
Draw Mode:
Eli Lilly and Co Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 287.43B | 950.17M | 789.65M | $ 28.32B | $ 5.95B | 6.13 | 44.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 3.40 | 1.30% | 08/12/22 | -1.70M | 0.50% |
Eli Lilly News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LLY Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 326.59 | 328.98 | 296.53 | 309.28 | 3,856,438 | -24.09 | -7.38% |
| 1 Month | 330.00 | 335.33 | 296.53 | 320.65 | 2,630,963 | -27.50 | -8.33% |
| 3 Months | 298.61 | 335.33 | 283.11 | 312.58 | 2,904,931 | 3.89 | 1.3% |
| 6 Months | 241.26 | 335.33 | 231.87 | 294.36 | 2,903,630 | 61.24 | 25.38% |
| 1 Year | 265.03 | 335.33 | 220.20 | 272.64 | 2,885,686 | 37.47 | 14.14% |
| 3 Years | 113.24 | 335.33 | 101.36 | 190.22 | 3,443,217 | 189.26 | 167.13% |
| 5 Years | 82.13 | 335.33 | 73.69 | 148.74 | 4,184,741 | 220.37 | 268.32% |
Eli Lilly Description
| Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. |